Journal article

Cross-National Comparisons of Sex Differences in Opportunities to Use Alcohol or Drugs, and the Transitions to Use

J Elisabeth Wells, Josep Maria Haro, Eli Karam, Sing Lee, Jean-Pierre Lepine, Ma Elena Medina-Mora, Hideyuki Nakane, Jose Posada, James C Anthony, Hui Cheng, Louisa Degenhardt, Matthias Angermeyer, Ronny Bruffaerts, Giovanni de Girolamo, Ron de Graaf, Meyer Glantz, Oye Gureje

Substance Use and Misuse | TAYLOR & FRANCIS INC | Published : 2011

Grants

Awarded by United States National Institute of Mental Health


Awarded by US Public Health Service


Awarded by Fogarty International Center


Awarded by National Institute on Drug Abuse


Awarded by European Commission


Awarded by Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain


Awarded by Ministerio de Ciencia y Tecnologia, Spain


Awarded by Japan Ministry of Health, Labour and Welfare


Awarded by National Institute of Psychiatry Ramon de la Fuente


Awarded by National Council on Science and Technology


Awarded by National Institute of Mental Health (NIMH)


Awarded by Robert Wood Johnson Foundation (RWJF)


Funding Acknowledgements

The World Mental Health Survey Initiative provided assistance with instrumentation, fieldwork, and data analysis. These activities were supported by the United States National Institute of Mental Health (R01MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R01-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline, and Bristol-Myers Squibb. These funders had no role other than funding. The work of the MSU-based authors (L.D., H.C., J.C.A.) was supported by the National Institute on Drug Abuse (K05DA015799; R01DA016558). The National Drug and Alcohol Research Centre (L. D.) receives funding from the Australian Government Department of Health and Ageing and L. D. also received support from an Australian NHMRC Senior Research Fellowship.Each country obtained funding for its own survey. The Chinese World Mental Health Survey Initiative is supported by the Pfizer Foundation. The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection, with supplemental support from the Saldarriaga Concha Foundation. The ESEMeD project is funded by the European Commission (Contracts QLG5-1999-01042; SANCO 2004123), the Piedmont Region (Italy), Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnologia, Spain (SAF 2000-158-CE), Departament de Salut, Generalitat de Catalunya, Spain, and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. The World Mental Health Japan (WMHJ) Survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour and Welfare. The Lebanese National Mental Health Survey (LEBANON) is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), the Fogarty International Center (FIRCA R01-TW006481), anonymous private donations to IDRAAC, Lebanon, and unrestricted grants from Janssen Cilag, Eli Lilly, GlaxoSmithKline, Roche, and Novartis. The Mexican National Comorbidity Survey (MNCS) is supported by The National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544-H), with supplemental support from the PanAmerican Health Organization (PAHO). The New Zealand Mental Health Survey (NZMHS) is supported by the New Zealand Ministry of Health, Alcohol Advisory Council, and the Health Research Council. The Nigerian Survey of Mental Health and Wellbeing (NSMHW) is supported by the WHO (Geneva), the WHO (Nigeria), and the Federal Ministry of Health, Abuja, Nigeria. The US National Comorbidity Survey Replication (NCS-R) is supported by the National Institute of Mental Health (NIMH; U01-MH60220), with supplemental support from the National Institute of Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (RWJF; Grant 044780), and the John W. Alden Trust.